Matthew Ros

Matthew Ros

Direktör/Styrelseledamot på COGENT BIOSCIENCES, INC.

Förmögenhet: 191 000 $ per 2026-06-30

59 år
Health Technology
Health Services
Consumer Services

Profil

Matthew E.
Ros
is currently an Independent Director at Cogent Biosciences, Inc. since 2019.
Formerly, served as Chief Executive Officer & Director at Fore Biotherapeutics, Inc. from 2022 to 2023.
Worked at Bristol Myers Squibb Co. as Senior Director from 1990 to 2007.
Held the position of Senior Vice President-Commercial Operations at ARIAD Pharmaceuticals, Inc. from 2009 to 2010.
Was Vice President & Head-Franchise at Genzyme Corp.
from 2012 to 2014.
Served as Associate Vice President at Sanofi from 2010 to 2012 and later as COO, VP & Global Head-Oncology Business Unit at Sanofi from 2014 to 2016.
Held the role of Chief Financial Officer at Epizyme, Inc. in 2021.
Held a trustee position at Cancer Care, Inc. Served as Chief Operating Officer at Verastem, Inc. in 2025.
Education includes an undergraduate degree from The State University of New York, conferred in 1988.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2025-04-01 50 000 ( 0,06 % ) 191 000 $ 2026-06-30
-.--%
2026-07-16 0 ( -.--% ) - $ 2026-06-30
2026-06-09 0 ( -.--% ) - $ 2026-06-30

Aktiva positioner av Matthew Ros

FöretagPositionStart
COGENT BIOSCIENCES, INC. Direktör/Styrelseledamot 2019-07-26

Tidigare kända positioner av Matthew Ros

FöretagPositionSlut
VERASTEM, INC. Verksamhetschef 2025-12-15
Verkställande Direktör 2023-08-01
EPIZYME, INC. Finansdirektör/CFO 2021-10-01
SANOFI Verksamhetschef 2016-05-01
Företagsledare/Principal 2014-12-01
Se detaljerna i Matthew Ross erfarenhet

Matthew Ross utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

96

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Matthew Ros